Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control
Background Chronic urticaria is a frequent and debilitating skin disease. Its symptoms commonly fluctuate considerably from day to day. As of yet, the only reliable tool to assess disease activity is the Urticaria Activity Score, which prospectively documents the signs and symptoms of urticaria for...
Gespeichert in:
| Veröffentlicht in: | Journal of allergy and clinical immunology 2014-05, Vol.133 (5), p.1365-1372.e6 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1372.e6 |
|---|---|
| container_issue | 5 |
| container_start_page | 1365 |
| container_title | Journal of allergy and clinical immunology |
| container_volume | 133 |
| creator | Weller, Karsten, MD Groffik, Adriane, MD Church, Martin K., PhD, DSc Hawro, Tomasz, MD Krause, Karoline, MD Metz, Martin, MD Martus, Peter, PhD Casale, Thomas B., MD Staubach, Petra, MD Maurer, Marcus, MD |
| description | Background Chronic urticaria is a frequent and debilitating skin disease. Its symptoms commonly fluctuate considerably from day to day. As of yet, the only reliable tool to assess disease activity is the Urticaria Activity Score, which prospectively documents the signs and symptoms of urticaria for several days. Objective We sought to develop and validate a novel patient-reported outcome instrument to retrospectively assess urticaria control, the Urticaria Control Test (UCT). Methods Potential UCT items were developed by using established methods (literature research and expert and patient involvement). Subsequently, item reduction was performed by using a combined approach, applying impact and regression analysis. The resulting UCT instrument was then tested for its validity, reliability, and screening accuracy. Results A 4-item UCT with a recall period of 4 weeks was developed based on 25 potential UCT items tested in 508 patients with chronic urticaria. A subsequent validation study with the 4-item UCT in 120 patients with chronic urticaria demonstrated that this new tool exhibits good convergent and known-groups validity, as well as excellent test-retest reliability. In addition, the screening accuracy to identify patients with urticaria with insufficiently controlled disease was found to be high. Conclusions The UCT is the first valid and reliable tool to assess disease control in patients with chronic urticaria (spontaneous and inducible). Its retrospective approach and simple scoring system make it an ideal instrument for the management of patients with chronic urticaria in clinical practice. |
| doi_str_mv | 10.1016/j.jaci.2013.12.1076 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1524421821</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0091674914000049</els_id><sourcerecordid>3284928881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c616t-b5a7d63d3e55180ab1cc2ec8f739602d0c5a00959da6f7cfbe2748bd4b1490473</originalsourceid><addsrcrecordid>eNqNks-K1TAYxYsoznX0CQQJiOCm1yRN2kRQGK5_YcCFM-uQJl81tW1qkl6YnY_is_hkpt7rDMxGVyHhd05ycr6ieEzwlmBSv-i3vTZuSzGptoTms6a-U2wIlk1ZC8rvFhuMJSnrhsmT4kGMPc77Ssj7xQllnFIs8ab48Qb2MPh5hCkhPVm014OzOjk_Id-h9BXQZUjO6OA02vkpBT-gC4jpJTr79XPOYBaWAWYfEljkl2T8CMhNMYXlj2nnA9IxQoxu-oKWazNzMHtY3Ov0EOHRcT0tLt-9vdh9KM8_vf-4OzsvTU3qVLZcN7aubAWcE4F1S4yhYETXVLLG1GLDdY7HpdV115iuBdow0VrWEiYxa6rT4vnBdw7--5IDqNFFA8OgJ_BLVIRTxigRlPwHSqRglMrV9ekttPdLmHKQlRL5ZsZFpqoDZYKPMUCn5uBGHa4UwWrtUvVq7VKtXSpC1dplVj05ei_tCPZa87e8DDw7AjoaPXRBT8bFG07wmjRizfPqwEH-372DoKLJtRmwLoBJynr3j4e8vqU3g5tyjcM3uIJ4k1hFqrD6vI7dOnWE5YnDTFa_ATPu07Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1518904458</pqid></control><display><type>article</type><title>Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Weller, Karsten, MD ; Groffik, Adriane, MD ; Church, Martin K., PhD, DSc ; Hawro, Tomasz, MD ; Krause, Karoline, MD ; Metz, Martin, MD ; Martus, Peter, PhD ; Casale, Thomas B., MD ; Staubach, Petra, MD ; Maurer, Marcus, MD</creator><creatorcontrib>Weller, Karsten, MD ; Groffik, Adriane, MD ; Church, Martin K., PhD, DSc ; Hawro, Tomasz, MD ; Krause, Karoline, MD ; Metz, Martin, MD ; Martus, Peter, PhD ; Casale, Thomas B., MD ; Staubach, Petra, MD ; Maurer, Marcus, MD</creatorcontrib><description>Background Chronic urticaria is a frequent and debilitating skin disease. Its symptoms commonly fluctuate considerably from day to day. As of yet, the only reliable tool to assess disease activity is the Urticaria Activity Score, which prospectively documents the signs and symptoms of urticaria for several days. Objective We sought to develop and validate a novel patient-reported outcome instrument to retrospectively assess urticaria control, the Urticaria Control Test (UCT). Methods Potential UCT items were developed by using established methods (literature research and expert and patient involvement). Subsequently, item reduction was performed by using a combined approach, applying impact and regression analysis. The resulting UCT instrument was then tested for its validity, reliability, and screening accuracy. Results A 4-item UCT with a recall period of 4 weeks was developed based on 25 potential UCT items tested in 508 patients with chronic urticaria. A subsequent validation study with the 4-item UCT in 120 patients with chronic urticaria demonstrated that this new tool exhibits good convergent and known-groups validity, as well as excellent test-retest reliability. In addition, the screening accuracy to identify patients with urticaria with insufficiently controlled disease was found to be high. Conclusions The UCT is the first valid and reliable tool to assess disease control in patients with chronic urticaria (spontaneous and inducible). Its retrospective approach and simple scoring system make it an ideal instrument for the management of patients with chronic urticaria in clinical practice.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2013.12.1076</identifier><identifier>PMID: 24522090</identifier><identifier>CODEN: JACIBY</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Allergic diseases ; Allergies ; Allergy and Immunology ; Biological and medical sciences ; development ; disease activity ; Disease control ; Family physicians ; Female ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Germany - epidemiology ; Humans ; Immunopathology ; Likert scale ; Male ; Medical sciences ; Middle Aged ; Patients ; Regression analysis ; Retrospective Studies ; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis ; Skin allergic diseases. Stinging insect allergies ; urticaria ; Urticaria - epidemiology ; Urticaria - pathology ; Urticaria - therapy ; validation</subject><ispartof>Journal of allergy and clinical immunology, 2014-05, Vol.133 (5), p.1365-1372.e6</ispartof><rights>American Academy of Allergy, Asthma & Immunology</rights><rights>2014 American Academy of Allergy, Asthma & Immunology</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited May 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c616t-b5a7d63d3e55180ab1cc2ec8f739602d0c5a00959da6f7cfbe2748bd4b1490473</citedby><cites>FETCH-LOGICAL-c616t-b5a7d63d3e55180ab1cc2ec8f739602d0c5a00959da6f7cfbe2748bd4b1490473</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0091674914000049$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28561781$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24522090$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Weller, Karsten, MD</creatorcontrib><creatorcontrib>Groffik, Adriane, MD</creatorcontrib><creatorcontrib>Church, Martin K., PhD, DSc</creatorcontrib><creatorcontrib>Hawro, Tomasz, MD</creatorcontrib><creatorcontrib>Krause, Karoline, MD</creatorcontrib><creatorcontrib>Metz, Martin, MD</creatorcontrib><creatorcontrib>Martus, Peter, PhD</creatorcontrib><creatorcontrib>Casale, Thomas B., MD</creatorcontrib><creatorcontrib>Staubach, Petra, MD</creatorcontrib><creatorcontrib>Maurer, Marcus, MD</creatorcontrib><title>Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>Background Chronic urticaria is a frequent and debilitating skin disease. Its symptoms commonly fluctuate considerably from day to day. As of yet, the only reliable tool to assess disease activity is the Urticaria Activity Score, which prospectively documents the signs and symptoms of urticaria for several days. Objective We sought to develop and validate a novel patient-reported outcome instrument to retrospectively assess urticaria control, the Urticaria Control Test (UCT). Methods Potential UCT items were developed by using established methods (literature research and expert and patient involvement). Subsequently, item reduction was performed by using a combined approach, applying impact and regression analysis. The resulting UCT instrument was then tested for its validity, reliability, and screening accuracy. Results A 4-item UCT with a recall period of 4 weeks was developed based on 25 potential UCT items tested in 508 patients with chronic urticaria. A subsequent validation study with the 4-item UCT in 120 patients with chronic urticaria demonstrated that this new tool exhibits good convergent and known-groups validity, as well as excellent test-retest reliability. In addition, the screening accuracy to identify patients with urticaria with insufficiently controlled disease was found to be high. Conclusions The UCT is the first valid and reliable tool to assess disease control in patients with chronic urticaria (spontaneous and inducible). Its retrospective approach and simple scoring system make it an ideal instrument for the management of patients with chronic urticaria in clinical practice.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Allergic diseases</subject><subject>Allergies</subject><subject>Allergy and Immunology</subject><subject>Biological and medical sciences</subject><subject>development</subject><subject>disease activity</subject><subject>Disease control</subject><subject>Family physicians</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Germany - epidemiology</subject><subject>Humans</subject><subject>Immunopathology</subject><subject>Likert scale</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Patients</subject><subject>Regression analysis</subject><subject>Retrospective Studies</subject><subject>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><subject>Skin allergic diseases. Stinging insect allergies</subject><subject>urticaria</subject><subject>Urticaria - epidemiology</subject><subject>Urticaria - pathology</subject><subject>Urticaria - therapy</subject><subject>validation</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNks-K1TAYxYsoznX0CQQJiOCm1yRN2kRQGK5_YcCFM-uQJl81tW1qkl6YnY_is_hkpt7rDMxGVyHhd05ycr6ieEzwlmBSv-i3vTZuSzGptoTms6a-U2wIlk1ZC8rvFhuMJSnrhsmT4kGMPc77Ssj7xQllnFIs8ab48Qb2MPh5hCkhPVm014OzOjk_Id-h9BXQZUjO6OA02vkpBT-gC4jpJTr79XPOYBaWAWYfEljkl2T8CMhNMYXlj2nnA9IxQoxu-oKWazNzMHtY3Ov0EOHRcT0tLt-9vdh9KM8_vf-4OzsvTU3qVLZcN7aubAWcE4F1S4yhYETXVLLG1GLDdY7HpdV115iuBdow0VrWEiYxa6rT4vnBdw7--5IDqNFFA8OgJ_BLVIRTxigRlPwHSqRglMrV9ekttPdLmHKQlRL5ZsZFpqoDZYKPMUCn5uBGHa4UwWrtUvVq7VKtXSpC1dplVj05ei_tCPZa87e8DDw7AjoaPXRBT8bFG07wmjRizfPqwEH-372DoKLJtRmwLoBJynr3j4e8vqU3g5tyjcM3uIJ4k1hFqrD6vI7dOnWE5YnDTFa_ATPu07Q</recordid><startdate>20140501</startdate><enddate>20140501</enddate><creator>Weller, Karsten, MD</creator><creator>Groffik, Adriane, MD</creator><creator>Church, Martin K., PhD, DSc</creator><creator>Hawro, Tomasz, MD</creator><creator>Krause, Karoline, MD</creator><creator>Metz, Martin, MD</creator><creator>Martus, Peter, PhD</creator><creator>Casale, Thomas B., MD</creator><creator>Staubach, Petra, MD</creator><creator>Maurer, Marcus, MD</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20140501</creationdate><title>Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control</title><author>Weller, Karsten, MD ; Groffik, Adriane, MD ; Church, Martin K., PhD, DSc ; Hawro, Tomasz, MD ; Krause, Karoline, MD ; Metz, Martin, MD ; Martus, Peter, PhD ; Casale, Thomas B., MD ; Staubach, Petra, MD ; Maurer, Marcus, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c616t-b5a7d63d3e55180ab1cc2ec8f739602d0c5a00959da6f7cfbe2748bd4b1490473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Allergic diseases</topic><topic>Allergies</topic><topic>Allergy and Immunology</topic><topic>Biological and medical sciences</topic><topic>development</topic><topic>disease activity</topic><topic>Disease control</topic><topic>Family physicians</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Germany - epidemiology</topic><topic>Humans</topic><topic>Immunopathology</topic><topic>Likert scale</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Patients</topic><topic>Regression analysis</topic><topic>Retrospective Studies</topic><topic>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</topic><topic>Skin allergic diseases. Stinging insect allergies</topic><topic>urticaria</topic><topic>Urticaria - epidemiology</topic><topic>Urticaria - pathology</topic><topic>Urticaria - therapy</topic><topic>validation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weller, Karsten, MD</creatorcontrib><creatorcontrib>Groffik, Adriane, MD</creatorcontrib><creatorcontrib>Church, Martin K., PhD, DSc</creatorcontrib><creatorcontrib>Hawro, Tomasz, MD</creatorcontrib><creatorcontrib>Krause, Karoline, MD</creatorcontrib><creatorcontrib>Metz, Martin, MD</creatorcontrib><creatorcontrib>Martus, Peter, PhD</creatorcontrib><creatorcontrib>Casale, Thomas B., MD</creatorcontrib><creatorcontrib>Staubach, Petra, MD</creatorcontrib><creatorcontrib>Maurer, Marcus, MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weller, Karsten, MD</au><au>Groffik, Adriane, MD</au><au>Church, Martin K., PhD, DSc</au><au>Hawro, Tomasz, MD</au><au>Krause, Karoline, MD</au><au>Metz, Martin, MD</au><au>Martus, Peter, PhD</au><au>Casale, Thomas B., MD</au><au>Staubach, Petra, MD</au><au>Maurer, Marcus, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2014-05-01</date><risdate>2014</risdate><volume>133</volume><issue>5</issue><spage>1365</spage><epage>1372.e6</epage><pages>1365-1372.e6</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><coden>JACIBY</coden><abstract>Background Chronic urticaria is a frequent and debilitating skin disease. Its symptoms commonly fluctuate considerably from day to day. As of yet, the only reliable tool to assess disease activity is the Urticaria Activity Score, which prospectively documents the signs and symptoms of urticaria for several days. Objective We sought to develop and validate a novel patient-reported outcome instrument to retrospectively assess urticaria control, the Urticaria Control Test (UCT). Methods Potential UCT items were developed by using established methods (literature research and expert and patient involvement). Subsequently, item reduction was performed by using a combined approach, applying impact and regression analysis. The resulting UCT instrument was then tested for its validity, reliability, and screening accuracy. Results A 4-item UCT with a recall period of 4 weeks was developed based on 25 potential UCT items tested in 508 patients with chronic urticaria. A subsequent validation study with the 4-item UCT in 120 patients with chronic urticaria demonstrated that this new tool exhibits good convergent and known-groups validity, as well as excellent test-retest reliability. In addition, the screening accuracy to identify patients with urticaria with insufficiently controlled disease was found to be high. Conclusions The UCT is the first valid and reliable tool to assess disease control in patients with chronic urticaria (spontaneous and inducible). Its retrospective approach and simple scoring system make it an ideal instrument for the management of patients with chronic urticaria in clinical practice.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>24522090</pmid><doi>10.1016/j.jaci.2013.12.1076</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0091-6749 |
| ispartof | Journal of allergy and clinical immunology, 2014-05, Vol.133 (5), p.1365-1372.e6 |
| issn | 0091-6749 1097-6825 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1524421821 |
| source | MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Adolescent Adult Aged Aged, 80 and over Allergic diseases Allergies Allergy and Immunology Biological and medical sciences development disease activity Disease control Family physicians Female Fundamental and applied biological sciences. Psychology Fundamental immunology Germany - epidemiology Humans Immunopathology Likert scale Male Medical sciences Middle Aged Patients Regression analysis Retrospective Studies Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Skin allergic diseases. Stinging insect allergies urticaria Urticaria - epidemiology Urticaria - pathology Urticaria - therapy validation |
| title | Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T11%3A47%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20validation%20of%20the%20Urticaria%20Control%20Test:%20A%C2%A0patient-reported%20outcome%20instrument%20for%20assessing%20urticaria%20control&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Weller,%20Karsten,%20MD&rft.date=2014-05-01&rft.volume=133&rft.issue=5&rft.spage=1365&rft.epage=1372.e6&rft.pages=1365-1372.e6&rft.issn=0091-6749&rft.eissn=1097-6825&rft.coden=JACIBY&rft_id=info:doi/10.1016/j.jaci.2013.12.1076&rft_dat=%3Cproquest_cross%3E3284928881%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1518904458&rft_id=info:pmid/24522090&rft_els_id=1_s2_0_S0091674914000049&rfr_iscdi=true |